Search
Patexia Research
Case number 3:22-cv-04635

HELSINN HEALTHCARE S.A. v. GLAND PHARMA LIMITED > Summary

Court Case Number 3:22-cv-04635

Filing Date Jul 18, 2022

Termination Date Dec 23, 2022

Court New Jersey District Court

Status Judgment - Judgment on Consent

JudgesZahid N. Quraishi, Lois H. Goodman

Plaintiff

Helsinn Healthcare SA

Defendant

Gland Pharma Limited

Related Patents

Doc No Title Issue date
11312698 Fosnetupitant chloride hydrochloride having improved stability Apr 26, 2022
10828297 Compositions and methods for treating centrally mediated nausea and vomiting Nov 10, 2020
10717721 Substituted piperaziniums for the treatment of emesis Jul 21, 2020
10624911 Physiologically balanced injectable formulations of fosnetupitant Apr 21, 2020
10208073 Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator Feb 19, 2019
09908907 Substituted piperaziniums for the treatment of emesis Mar 6, 2018
09403772 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator Aug 2, 2016
09186357 Compositions and methods for treating centrally mediated nausea and vomiting Nov 17, 2015
08895586 Methods of treating emesis Nov 25, 2014
08426450 Substituted 4-phenyl pyridines having anti-emetic effect Apr 23, 2013
Menu